Discontinued — last reported Q2 '23

Investing

Acquisitions

Medline, Inc. Acquisitions increased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 100.0%, from -$6.00M to $0.00.

Analysis

StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ4 2016
Last reportedQ2 2023

How to read this metric

High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.

Detailed definition

This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...

Peer comparison

Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.

Metric ID: acquisitions

Historical Data

10 periods
 Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q1 '26
Value$4.00M$4.00M$4.00M$4.00M$281.50M$281.50M$281.50M$281.50M-$6.00M$0.00
QoQ Change+0.0%+0.0%+0.0%>999%+0.0%+0.0%+0.0%-102.1%+100.0%
YoY Change>999%>999%>999%>999%-102.1%+100.0%
Range-$6.00M$281.50M
CAGR-100.0%
Avg YoY Growth>999%
Median YoY Growth>999%

Frequently Asked Questions

What is Medline, Inc. 's acquisitions?
Medline, Inc. (MDLN) reported acquisitions of $0.00 in Q1 2026.
How has Medline, Inc. 's acquisitions changed year-over-year?
Medline, Inc. 's acquisitions increased by 100.0% year-over-year, from -$6.00M to $0.00.
What does acquisitions mean?
Cash spent to acquire other companies or businesses, net of cash received in the deal.